Filter
1528
Filtered Results: 1528
Text search:
pharmaceutical
policies
Featured
Recommendations
138
New Publications
438
Language
Document type
No document type
808
Studies & Reports
318
Guidelines
205
Strategic & Response Plan
80
Manuals
64
Training Material
16
Situation Updates
13
Fact sheets
13
Resource Platforms
6
Brochures
3
Infographics
2
Countries / Regions
Kenya
66
Global
66
Ethiopia
59
India
51
South Africa
39
Nigeria
36
Western and Central Europe
36
Uganda
33
Sierra Leone
28
Nepal
25
Liberia
25
Malawi
24
Ghana
23
Namibia
23
Tanzania
22
Bangladesh
22
Zambia
22
Africa
21
Ukraine
20
Rwanda
19
Cambodia
16
Lesotho
15
Latin America and the Carribbean
15
South–East Asia Region
15
Eastern Europe
15
Indonesia
14
Syria
13
Zimbabwe
13
Philippines
13
Myanmar / Burma
11
West and Central Africa
10
East and Southern Africa
9
Botswana
9
Congo, Democratic Republic of
7
Eastern Europe and Central Asia
7
Eswatini/ Swaziland
7
Cameroon
6
Senegal
6
Asia
6
Middle East and North Africa
6
Thailand
5
Haiti
5
Germany
5
Pakistan
5
Albania
4
Burkina Faso
4
Mozambique
4
Venezuela
4
Western Pacific Region
4
South Sudan
4
Benin
3
Laos
3
Afghanistan
3
Peru
3
Guinea
3
USA
3
Vietnam
3
Brazil
3
China
2
Fiji
2
Lithuania
2
Jordan
2
North America
2
Lebanon
2
Egypt
2
Sudan
2
Mali
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
Chile
1
Iran
1
Kyrgyzstan
1
Niger
1
Mongolia
1
Bulgaria
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Southern Africa
1
Argentina
1
Papua New Guinea
1
Sri Lanka
1
Yemen
1
Romania
1
Palestine
1
Central African Republic
1
Angola
1
Chad
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
657
Public Health
88
Clinical Guidelines
84
Key Resources
77
Women & Child Health
39
Pharmacy & Technologies
20
Capacity Building
9
Toolboxes
AMR
166
COVID-19
115
Pharmacy
107
TB
82
Mental Health
81
HIV
71
Rapid Response
46
Planetary Health
45
NCDs
38
NTDs
33
Global Health Education
33
Health Financing Toolbox
31
Caregiver
27
Conflict
25
Ebola & Marburg
13
Refugee
10
Disability
8
Specific Hazards
7
Natural Hazards
7
Polio
6
Zika
3
Cholera
2
Social Ethics
2
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
Climate change (CC) impacts on health outcomes, both direct and indirect, are sufficient to jeopardize achieving the World Bank Group’s visions and agendas in poverty reduction, population resilience, and health, nutrition and population (HNP). In the last 5 years, the number of voices calling for...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
This report aims to raise awareness about the role that the reform of public health laws can play in advancing the right to health and in creating the conditions for people to live healthy lives. By encouraging a better understanding of how public health law can be used to improve the health of the ...
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers. Part B
Jamieson D and Kellerman S. Journal of the International AIDS Society 2016, 19:20917 http://www.jiasociety.org/index.php/jias/article/view/20917 | http://dx.doi.org/10.7448/IAS.19.1.20917
This compendium collates current tools and resources on quality improvement developed by the WHO Service Delivery and Safety Department and provides examples of how the tools and resources have been applied in country settings. The target audience for this document are ministries of health, facility...
Health, Rights and Drugs
recommended
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Some of the key findings of the report include:
Almost 80% of the general public are concerned about developing dementia at some point and 1 in 4 people think that there is nothing we can do to prevent dementia
35% of carers across the world said that they have hidden the diagnosis of de...
USAID funded/ Primary Health Care Project in Iraq (PHCPI) in cooperation with Iraqi Ministry of Health (MOH) aims to promote Primary Health Care (PHC) services provided by Primary Health Care Clinics (PHCCs) in Iraq in order to achieve the development goal in enhancing the PHC provision system throu...
Extreme heat events (EHEs) are a leading cause of weather-related injury and death in the United States, and under a changing climate, these meteorological episodes are predicted to increase in both frequency and intensity. Prolonged heat exposure from EHEs places an increased strain on the heart an...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
The report shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
Towards the Peoples Health Assembly Book - 1
